Mauritius vs Zimbabwe: Number of clinical trials

Mauritius
2 trials
in 2023
Zimbabwe
2 trials
in 2024
Mauritius rank
108th
Zimbabwe rank
108th

Number of clinical trials over time

  • Mauritius
  • Zimbabwe
02468200320132024

How they compare

Mauritius currently reports 2 trials against 2 trials in Zimbabwe, a difference of 0 trials.

Across all 5 years both countries report, Zimbabwe has been ahead every year.

Mauritius ranks 108th and Zimbabwe ranks 108th of 153 countries.

Zimbabwe has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Mauritius Zimbabwe Difference Ahead
2010s 1 trials 2.67 trials 1.67 trials Zimbabwe
2020s 2.5 trials 5 trials 2.5 trials Zimbabwe

Averages of every year both report within each decade.

Frequently asked questions

Which has higher number of clinical trials, Mauritius or Zimbabwe?
Mauritius, at 2 trials against 2 trials in Zimbabwe as of 2023.
What is the difference in number of clinical trials between Mauritius and Zimbabwe?
0 trials, with Mauritius ahead.
How many years of comparable data are there for Mauritius and Zimbabwe?
5 years are reported by both, from 2011 to 2023.
How do Mauritius and Zimbabwe rank globally for number of clinical trials?
Mauritius ranks 108th and Zimbabwe ranks 108th of 153 countries.
Where does this data come from?
ClinicalTrials.gov (2025) – with major processing by Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Number of clinical trials
Unit
trials
Source
ClinicalTrials.gov (2025) – with major processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
153 places, 2,621 data points, 2000–2024
Last refreshed

Annual number of completed clinical trials registered in the ClinicalTrials.gov database for each country. Registration in the ClinicalTrials database is mandatory for trials in the United States, but voluntary for other countries.